
    
      This study records severity of depression and relapse in patients treated for a major
      depressive disorder with electroconvulsive treatment (ECT)in a period og 6 month after end of
      ECT treatment. Patients will be randomized into four groups treated with escitalopram 10 mg,
      20 mg, 30 mg or nortriptylin 100 mg daily dosages. The primary outcome measure is relapse and
      secondary outcome measure is tolerability.

      The study is a multicenter trial within Denmark.
    
  